IA
UTHR icon

Icon Advisers’s United Therapeutics UTHR Stock Holding History

Icon Advisers’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19K Buy
+35
New +$19.7K ﹤0.01% 178
2026
Q1 		– Sell
-50
Closed -$24.4K – 192
2025
Q4 		$24.4K Hold
50
– – 0.01% 165
2025
Q3 		$21K Hold
50
– – ﹤0.01% 158
2025
Q2 		$14.4K Buy
+50
New +$14.9K ﹤0.01% 169
2025
Q1 		– Sell
-50
Closed -$17.6K – 187
2024
Q4 		$17.6K Buy
+50
New +$18.4K ﹤0.01% 156
2024
Q3 		– Sell
-50
Closed -$15.9K – 190
2024
Q2 		$15.9K Buy
+50
New +$13.2K ﹤0.01% 164
2013
Q3 		– Sell
-48,300
Closed -$3.18M – 371
2013
Q2 		$3.18M Buy
+48,300
New +$3.11M 0.24% 104

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Icon Advisers's UTHR Position: Q2 2026 in Review

Icon Advisers opened a new position in United Therapeutics (UTHR) in Q2 2026: 35 shares worth $19K. The stake represents ﹤0.01% of the portfolio and ranks #178 among its holdings. This is a return to the name: Icon Advisers previously reported a position in UTHR as recently as Q4 2025.

Icon Advisers first reported a position in UTHR in Q2 2013 and has held it in 7 quarters since. The position peaked at $3.18M in Q2 2013. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Icon Advisers held 35 shares of United Therapeutics worth $19K as of Q2 2026.
  • United Therapeutics was a new Icon Advisers position in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Icon Advisers's portfolio in Q2 2026, its #178 holding.
  • Icon Advisers first reported a position in United Therapeutics in Q2 2013 and has held it in 7 quarters since.
  • Icon Advisers's United Therapeutics position peaked at $3.18M in Q2 2013.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Icon Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.